50 Stocks Moving In Wednesday's Mid-Day Session



  • Arbutus Biopharma Corporation ABUS climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's appeal to invalidate two of Arbutus' patents on drug-delivery technology used in the former's COVID-19 vaccine.
  • OceanPal Inc. OP shares climbed 51.3% to $7.90 after completion of spinoff from Diana Shipping on Tuesday.
  • Advanced Human Imaging Limited AHI surged 39% to $4.3201 following circulation of apparent co. press release dated Dec. 1: 'Advanced Human Imaging concludes Definitive agreements with Canadian based Cubert.'
  • Context Therapeutics Inc. CNTX rose 37.7% to $9.48 after jumping 23% on Tuesday.
  • MDJM Ltd MDJH jumped 32.3% to $3.48.
  • Build-A-Bear Workshop, Inc. BBW surged 32.3% to $22.57 after the company reported better-than-expected Q3 results and raised FY21 guidance. The company also announced a special dividend and a share buyback.
  • Ardelyx, Inc. ARDX gained 24.5% to $1.42 after Citigroup raised its price target on the stock $7 to $13.
  • Ambarella, Inc. AMBA shares gained 23.4% to $221.46 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
  • Stronghold Digital Mining, Inc. SDIG gained 21.5% to $20.95 after the company announced better-than-expected Q3 sales results.
  • Roivant Sciences Ltd. ROIV jumped 18.1% to $7.83. Roivant Sciences, last month, posted a Q2 loss of $0.32 per share.
  • Stran & Company, Inc. STRN surged 19.3% to $4.20.
  • BriaCell Therapeutics Corp. BCTX rose 18% to $11.63 following Seeking Alpha blogpost from contributor 'AAA Investments' 'Why BCTX Is Undervalued - PT $30+.'
  • Marpai, Inc. MRAI gained 16.7% to $4.48.
  • Sensus Healthcare, Inc. SRTS gained 16.5% to $7.16 after the company announced the signing of an exclusive U.S. distribution agreement with Mattioli Eng. Italia for its TransDermal Infusion System non-invasive drug delivery system.
  • Quotient Limited QTNT jumped 15.8% to $2.4550. Quotient named Mr. Esteban Uriarte as the Company’s Chief Manufacturing Operations Officer.
  • Cyngn Inc. CYN surged 14.3% to $6.03.
  • PetVivo Holdings, Inc. PETV rose 13.7% to $3.2992.
  • ImmunoGen, Inc. IMGN gained 13% to $6.98 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $7 to $12. ImmunoGen announced proposed public offering of $175 million of common stock.
  • Box, Inc. BOX shares rose 12.2% to $26.27 after the company reported better-than-expected Q3 results and issued EPS guidance. The company also increased its buyback to $700 million.
  • Skylight Health Group Inc. SLHG gained 12.1% to $1.4795 after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a Q3 net loss of $3.9 million.
  • Molecular Templates, Inc. MTEM surged 11.5% to $4.47. Molecular Templates provided corporate update and outlined 2022 milestones.
  • Zogenix, Inc. ZGNX gained 11% to $12.49. The FDA has granted Priority Review to Zogenix’s supplemental marketing application seeking approval for Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS) childhood-onset epilepsy.
  • Five Point Holdings, LLC FPH rose 9.8% to $5.92.
  • Birks Group Inc. BGI gained 9.6% to $4.5499.
  • Landec Corporation LNDC rose 8.8% to $8.65.
  • The Goodyear Tire & Rubber Company GT gained 8.6% to $21.85

Check out these big penny stock gainers and losers


  • BeyondSpring Inc. BYSI shares dipped 55.7% to $5.66 after the company announced the FDA issued a Complete Response Letter related to the company's plinabulin New Drug Application. HC Wainwright & Co. downgraded BeyondSpring from Buy to Neutral.
  • Aditxt, Inc. ADTX shares fell 25.2% to $0.8746 after reporting a proposed public offering of common stock and warrants.
  • Pioneer Power Solutions, Inc. PPSI dipped 23.8% to $7.70.
  • Biofrontera Inc. BFRI fell 22.4% to $4.6481. Biofrontera recently posted Q3 loss of $2.00 per share.
  • AeroClean Technologies, Inc. AERC dropped 22.2% to $19.45.
  • CTI BioPharma Corp. CTIC fell 21.6% to $1.7650 after the company said the FDA has extended the review period for the new drug application for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis with a baseline platelet count of less than 50 × 109/L.
  • Cumberland Pharmaceuticals Inc. CPIX fell 21.4% to $3.9517. Cumberland Pharmaceuticals shares jumped 128% on Tuesday after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
  • NuZee, Inc. NUZE fell 20.4% to $3.70.
  • Petros Pharmaceuticals, Inc. PTPI dropped 16.7% to $2.38. Petros Pharmaceuticals recently announced a 3.33 million share offering at $3 per share.
  • Aptevo Therapeutics Inc. APVO fell 15.6% to $8.40.
  • Longeveron Inc. LGVN fell 15.2% to $22.28 after the company announced a private placement of approximately $20.5 million of its common stock and warrants.
  • Allbirds, Inc. BIRD dropped 15.1% to $16.33 after reporting a wider quarterly loss.
  • ThredUp Inc. TDUP fell 13.7% to $16.15.
  • Arteris, Inc. AIP dropped 13.7% to $23.43. Arteris reported a Q3 loss of $0.21per share.
  • iSpecimen Inc. ISPC fell 12.6% to $16.14.
  • GBS Inc. GBS fell 10.6% to $1.77. GBS shares gained 22% on Tuesday after the company announced it will commence preparation for clinical trials of its rapid SARS-CoV-2 Antibody test following the recent successful completion of a clinical validation study.
  • NLS Pharmaceutics AG NLSP fell 10.1% to $1.8250. NLS Pharmaceuticals shares gained 16% on Tuesday after the company announced final results from a preclinical study for NLS-4. The company believes NLS-4 offers promise to become a foundational treatment for the chronic fatigue associated with the symptoms of Long-Covid.
  • Sweetgreen, Inc. SG dipped 10% to $34.35.
  • 8x8, Inc. EGHT fell 9.7% to $19.44. 8x8 announced plans to buy Fuze in $250 million in stock and cash.
  • Moderna, Inc. MRNA fell 9.6% to $318.55 after The Patent Trial and Appeals Board turned down the company's appeal to invalidate two of Arbutus' patents on drug-delivery technology. The stock has been volatile amid COVID-19 omicron variant concerns.
  • Clarus Therapeutics Holdings, Inc. CRXT fell 9.1% to $5.20. Clarus Therapeutics shares jumped 10% on Tuesday after the company announced issuance of two new patents for JATENZO.
  • Invacare Corporation IVC dropped 8.8% to $2.4975. Invacare announced realignment of EMEA & APAC Businesses.
  • salesforce.com, inc. CRM shares fell 7.5% to $263.70. salesforce reported upbeat results for its third quarter, but issued weak forecast.
  • Guardforce AI Co., Limited. GFAI shares fell 6.8% to $1.6217. Guardforce AI Co shares gained 20% on Tuesday after the company announced it won a five year bid to operate a Consolidated Cash Center in Hadyai, Thailand.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMaterialsMid-Day MoversSpecialty ChemicalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!